Jong Ho Lee

Jong Ho Lee

Auto-generated profile, based on publicly available information

Jong Ho Lee

Department of Plastic and Reconstructive Surgery, School of Medicine, Kyungpook National University, Daegu 41944, Republic of Korea

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

1 January 2022 in Journal of Breast Cancer
Verified
Journal Article
Open access
PDF file
BKbyeongju kang
byeongju kang
JLJong Ho Lee
Jong Ho Lee
JLJeeyeon Lee
Jeeyeon Lee
JJJin Hyang Jung
Jin Hyang Jung
WKWan Wook Kim
Wan Wook Kim
HPHo Yong Park
Ho Yong Park
Kang B, et al. J Breast Cancer. 2022 Jun;25:e27. https://doi.org/10.4048/jbc.2022.25.e27

Verified
Journal Article
Open access
PDF file
JLJoon Seok Lee
Joon Seok Lee
GKGyeonghwa Kim
Gyeonghwa Kim
JLJong Ho Lee
Jong Ho Lee
JRJeong Yeop Ryu
Jeong Yeop Ryu
EOEunJung Oh
EunJung Oh
HCHo Yun Chung
Ho Yun Chung
The clinical aspects of hypertrophic scarring vary according to personal constitution and body part. However, the mechanism of hypertrophic scar (HS) formation remains unclear. MicroRNAs (miRNAs) are known to contribute to HS formation, however, their detailed role remains unknown. In this study, candidate miRNAs were identified and analyzed as biomarkers of hypertrophic scarring for future clinical applications. HSfibroblasts and normal skin fibroblasts from patients were used for profiling and validation of miRNAs. An HS mouse model with xenografted human skin on nude mice was established. The miRNA expression between normal human, normal mouse, and mouse HS skin tissues was compared. Circulating miRNA expression levels in the serum of normal mice and mice with HSs were also analyzed. Ten upregulated and twenty-one downregulated miRNAs were detected. Among these, miR-365a/b-3p and miR-16-5p were identified as candidate miRNAs with statistically significant differences; miR-365a/b-3p was significantly upregulated (p = 0.0244). In mouse studies, miR-365a/b-3p expression levels in skin tissue and serum were higher in mice with HSs than in the control group. These results indicate that miRNAs contribute to hypertrophic scarring and that miR-365a/b-3p may be considered a potential biomarker for HS formation.

Verified
Journal Article
Open access
PDF file
JLJoon Seok Lee
Joon Seok Lee
GKGyeonghwa Kim
Gyeonghwa Kim
JLJong Ho Lee
Jong Ho Lee
JRJeong Yeop Ryu
Jeong Yeop Ryu
EOEunJung Oh
EunJung Oh
HCHo Yun Chung
Ho Yun Chung
Arteriovenous malformations (AVMs) are congenital vascular anomalies with a poor prognosis. AVMs are considered intractable diseases, as there is no established approach for early diagnosis and treatment. Therefore, this study aimed to provide new evidence by analyzing microRNAs (miRNAs) associated with AVM. We present fundamental evidence for the early diagnosis and treatment of AVM by analyzing miRNAs in the endothelial cells of AVMs. This study performed sequencing and validation of miRNAs in endothelial cells from normal and AVM tissues. Five upregulated and two downregulated miRNAs were subsequently analyzed under hypoxia and vascular endothelial growth factor (VEGF) treatment by one-way analysis of variance (ANOVA). Under hypoxic conditions, miR-135b-5p was significantly upregulated in the AVM compared to that under normal conditions, corresponding to increased endothelial activity (p-value = 0.0238). VEGF treatment showed no significant increase in miR-135b-5p under normal conditions, however, a surge in AVM was observed. Under both hypoxia and VEGF treatment, comparison indicated a downregulation of miR-135b-5p in AVM. Therefore, miR-135b-5p was assumed to affect the pathophysiological process of AVM and might play a vital role as a potential biomarker of AVMs for application related to diagnosis and treatment.

21 October 2022 in The Breast Journal
Verified
Journal Article
Open access
PDF file
JLJong Ho Lee
Jong Ho Lee
JRJeong Yeop Ryu
Jeong Yeop Ryu
KCKangyoung Choi
Kangyoung Choi
JYJung Dug Yang
Jung Dug Yang
HCHo Yun Chung
Ho Yun Chung
JLJoon Seok Lee
Joon Seok Lee
Background. A combination of the reduction mammoplasty technique and breast reconstruction allows surgeons to lift ptotic breasts through local flaps and skin reduction during surgery for breast cancer. This study presents a reliable course for the combination of partial and skin or nipple-sparing mastectomy with reduction-reconstruction surgery. Methods. Fifty-seven patients underwent a partial mastectomy before reduction mammoplasty of both breasts during the same time period between 2014 and 2021 at our institution and thirteen patients underwent skin or nipple-sparing mastectomy, breast reconstruction with an extended latissimus dorsi flap or silicone implant, and aesthetic reduction mammoplasty of the contralateral breast during the same time period. Additional photos were obtained preoperatively, immediately after the operation, and at one, three, six, and twelve months postoperatively. Patient satisfaction was evaluated preoperatively and postoperatively and postoperative complications were noted. Results. Among the patients who underwent a partial mastectomy, the mean age was 45.18±11.05 years, the mean body mass index (BMI) was 26.74±3.53kg/m2, and the mean preoperative right and left breast volumes were 663.85 (±28.12) cc and 664.34 (±37.13) cc, respectively, and the mean excised mass weight was 177.74 (±213.93) g. Among the patients who underwent a skin-sparing mastectomy, the mean age was 51.62±8.96 years, the mean BMI was 26.91±4.34kg/m2, and the mean preoperative right and left breast volumes were 624.17 (±98.52) cc and 562.31 (±80.81) cc, respectively, and the mean excised mass weight was 618.05 (±338.17) g. Four patients (5.3) in the partial mastectomy group had fat necrosis. The mean patient satisfaction score was higher postoperatively in both groups. Conclusion. Patients with breast cancer and large and/or ptotic breasts can successfully undergo reduction mammoplasty for both breasts immediately following partial mastectomy and nipple or skin-sparing mastectomy.

1 December 2013 in Transfusion and Apheresis Science
Verified
Journal Article
Closed access
MKMiyoung Kim
Miyoung Kim
HKHyung Suk Kim
Hyung Suk Kim
YKYang Hyun Kim
Yang Hyun Kim
JCJi Seon Choi
Ji Seon Choi
HYHoon Joo Yang
Hoon Joo Yang
KHKyou-Sup Han
Kyou-Sup Han